Concepedia

Author

Lucia Cuppini

Fondazione IRCCS Istituto Neurologico Carlo Besta

Also Known As

Alessandro Perin, Arndt Hartmann, Bianca Pollo, Christine Stoehr, Francesco DiMeco, Gaetano Finocchiaro, John Houck, Kalkanis, Steven, L Cuppini, L. Cuppini

64

Publications

43.6K

Citations

40

H-Index

45

Concepts

All Affiliations

Fondazione IRCCS Istituto Neurologico Carlo BestaEuropean Institute of OncologyMolecular Oncology (United States)Harvard UniversityBroad Institute
LC

About

Lucia Cuppini is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

1.2K

2

Engineering

2

2

935

3

Health Sciences

1

1

141

4

Natural Sciences

1

1

54

5

Biochemistry

1

1

54

Lucia Cuppini

×

13

Publications

2.4K

Citations

13

H-Index

YearCitations

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines

Kyle Ellrott, Matthew H. Bailey, Gordon Saksena,

Cell Systems

2018

895

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

Franz X. Schaub, Varsha Dhankani, Ashton C. Berger,

Cell Systems

2018

434

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo,

Cell

2018

425

Is fluorescein-guided technique able to help in resection of high-grade gliomas?

Francesco Acerbi, Morgan Broggi, Marica Eoli,

Neurosurgical FOCUS

2014

158

Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases

Francesco Acerbi, Morgan Broggi, Marica Eoli,

Acta Neurochirurgica

2013

141

The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells

Josée Golay, Lucia Cuppini, F. Leoni,

Leukemia

2007

106

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates

Serena Pellegatta, Marica Eoli, Simona Frigerio,

OncoImmunology

2013

64

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8 <sup>+</sup> T cell activation in the presence of adjuvant temozolomide

Serena Pellegatta, Marica Eoli, Valeria Cuccarini,

OncoImmunology

2017

62

LAB-ANGIOGENESIS AND INVASION

M. A. Proescholdt, Marsha J. Merrill, Eva-Maria Stoerr,

Neuro-Oncology

2012

54

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

Valeria Cuccarini, Alessandra Erbetta, Mariangela Farinotti,

Journal of Neuro-Oncology

2015

40

Page 1